Capability
ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy
How does ArtiQ's AI software interpret complex pulmonary function tests to detect conditions such as asthma, COPD and fibrosis?
ArtiQ: A small Belgian spin-off is quietly reshaping how doctors diagnose lung diseases. Defence-finance analysis; 35-page sourced DFM PDF report.
This public thread presents the concise analytical answer. The complete evidence, source base and assessment are available below.
Part of our Research, Universities & Deep Tech and Defence & Dual-Use Companies coverage →
Original DFM publication · DFM Analysis report · 2025-08-18
A small Belgian spin-off is quietly reshaping how doctors diagnose lung diseases. ArtiQ emerged from a university lab with a clear vision: use artificial intelligence to interpret complex pulmonary function tests faster and more accurately than human experts.
In just a few years, its software has analyzed tens of thousands of lung tests at Belgian hospitals, proving that machine learning can rival top pulmonologists in detecting conditions like asthma, COPD, and fibrosis . This success has not only attracted patients and physicians – it has also drawn the attention of global industry.
This analysis answers: How does ArtiQ's AI software interpret complex pulmonary function tests to detect conditions such as asthma, COPD and fibrosis? How mature is its diagnostic AI, validated on tens of thousands of tests in Belgian hospitals, and what is its dual-use relevance? Who are its partners and customers, and what global industry interest has it attracted? What capability gaps and dependencies affect this Belgian medical-AI spin-off?
Key takeaways
- This success has not only attracted patients and physicians – it has also drawn the attention of global industry.
Choose how to continue
Go deeper on this question
Full sourced report
ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy
View the report →
Keep getting the analysis
DFM publishes new analysis on Autonomy, Robotics & AI every week.
Original DFM analysis
ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy
The publication details above identify the source used for this public thread.
FAQ
What is ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy?
ArtiQ emerged from a university lab with a clear vision: use artificial intelligence to interpret complex pulmonary function tests faster and more accurately than human experts.
Why does ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy matter for European defence?
In just a few years, its software has analyzed tens of thousands of lung tests at Belgian hospitals, proving that machine learning can rival top pulmonologists in detecting conditions like asthma, COPD, and fibrosis .
Related DFM Platform threads
Explore this category Strategic Autonomy
Professional requests (internal interest signal — not a marketplace; nothing is charged or promised)
See Professional & Institutional Access — plans, group/institutional seats and contact →
Defence Finance Monitor is an analytical and informational product. It does not constitute investment advice, financial advice or a recommendation to buy or sell securities. Subscriptions run on DFM Analysis. Payments for Professional Packs are processed securely by Stripe at checkout.